JPRN-UMIN000003023招募中未知
Efficacy and safety of step-down therapy with ciclesonide once-daily and beta2-agonist tulobuterol patch in asthma patients receiving salmeterol/fluticasone propionate diskus: multicenter study - Efficacy and safety of step-down therapy with ciclesonide once-daily and beta2-agonist tulobuterol patch in asthma patients receiving salmeterol/fluticasone propionate diskus
Hiroshima Allergy Research Group0 个研究点目标入组 150 人开始时间: 2010年1月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)addition or dose-change of antiasthma medications (except for salmeterol/fluticasone propionate diskus) within previous 3 months 2)use of ciclesonide and beta2-agonist tulobuterol patch within previous 3 months 3)corresponding to contraindication on accompanied note of study medication 4)difficult to answer of self administered questionnaire 5)physician decided the patient is unsuitable to enrollment
研究者
相似试验
进行中（未招募）
1 期
Effect of low dose continuous treatment with Ciclesonide over one year on the time to first exacerbation in children with mild asthma versus intermittent treatment for exacerbations - POPCICLEAsthma bronchialMedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-003736-34-HUycomed Canada Inc.240
招募中
2 期
A clinical study to evaluate the comparative efficacy of three Unani drugs in the treatment of Hepatitis B carriersCTRI/2018/06/014642DG Central Council for Research in Unani Medicine
尚未招募
不适用
This study will investigate the anticancer effect and treatment-related safety when focused ultrasound stimuli is given for the pancreatic cancer in patients with unresectable pancreatic cancer who need chemotherapy in a prospective mannerNeoplasmsKCT0006302Seoul National University Hospital60
已完成
2 期
Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid®) (CR2) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia (CLL): a phase II trialChronic Lymphatic Leukemia10024324CLLNL-OMON36713HOVO62
尚未招募
2 期
Study to verify whether using a reduced dose of chemotherapy is safe and effective among children with Non-Hodgkin LymphomaCTRI/2024/06/069405Cancer Institute WIA